Search

-- Opportunity to Define a New Myelofibrosis Treatment Paradigm with Top-Line Data Readout from Phase 3 SENTRY Trial Evaluating Selinexor in Combination with Ruxolitinib in Patients with JAKi-Naȯve Myelofibrosis Anticipated [...]

Preclinical Data with OPN-6602 in Multiple Myeloma Show 100% Tumor Regression in Combination Treatment Studies SAN DIEGO -- Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development [...]

-- Preliminary results from 86 patients enrolled in the Phase 2 pivotal iMMagine-1 study of anito-cel demonstrated 97% ORR and 62% CR/sCR at a median follow-up of 9.5 months -- [...]

FORT MYERS, Fla: Florida Cancer Specialists & Research Institute has issued the following news release: Florida Cancer Specialists & Research Institute, LLC (FCS) is contributing to breakthroughs in the treatment [...]

London: NHS England has issued contract notice/solicitation for 'CM/TNS/24/5719 - NHS National Framework for the supply of Pomalidomide' Reference no: CF-2723900D0O000000rwimUAA Posted on: 28 November 2024 Notice Type: Service Deadline [...]

Luxembourg: Fakultni nemocnice Olomouc has issued contract notice/solicitation for 'LP containing pomalidomide 2024' Reference no: 698948-2024 Posted on: 15/11/2024 Notice Type: Supplies Deadline for All responses: 18/12/2024 Description: The subject [...]

2024 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Researchers detail new data in multiple myeloma. According to news reporting out of Brindisi, Italy, [...]

2024 NOV 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- New research on multiple myeloma is the subject of a new report. According to news [...]

Uruguay based LABORATORIO GADOR S A has secured contract from Ministerio de Salud Publica for DARATUMUMAB POMALYDOMIDE ITEM Nº2 POMALIDOMIDE (CODE ARTICULE 75506). The value of the contract is worth [...]

Uruguay based JOHNSON Y JOHNSON DE URUGUAY S A has secured contract from Ministerio de Salud Publica for DARATUMUMAB Pomalidomide Item Nº1 DARATUMUMAB (Injectable) (Code Article 76528). The value of [...]

Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility [...]

Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility [...]

Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility [...]

Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility [...]

Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility [...]

Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility [...]

Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility [...]

Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility [...]

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb is a differentiated company, led [...]

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb is a differentiated company, led [...]

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb is a differentiated company, led [...]

Byline: Anthony Vecchione Bridgewater-based Sanofi said March 2 that the U.S. Food and Drug Administration approved Sarclisa in combination with pomalidomide and dexamethasone for the treatment of adults with relapsed [...]

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb is a differentiated company, led [...]

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb is a differentiated company, led [...]

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb is a differentiated company, led [...]

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb is a differentiated company, led [...]

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb is a differentiated company, led [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]

At Bristol-Myers Squibb we are focused on finding and developing innovative medicines and delivering them to patients as quickly and efficiently as possible. In the UK, and around the world, [...]